Employees: 32 (2023.0)Legal category: SCA (commandite par actions)Size: ETICreation date: 1983-01-01 (43 years)Status: ActiveBusiness sector: Commerce de gros (commerce interentreprises) de produits pharmaceutiquesLocation: RUEIL MALMAISON (92500), Hauts-de-Seine
LABORATOIRES ALCON : revenue, balance sheet and financial ratios
LABORATOIRES ALCON is a French company
founded 43 years ago,
specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques.
Based in RUEIL MALMAISON (92500),
this company of category ETI
shows in 2024 a revenue of 236.0 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - LABORATOIRES ALCON (SIREN 652009044)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
236 016 966 €
220 179 156 €
203 774 920 €
192 226 751 €
162 068 820 €
192 322 742 €
188 072 981 €
228 208 328 €
304 805 384 €
Net income
7 367 506 €
5 466 750 €
6 361 046 €
4 670 145 €
3 214 172 €
4 681 837 €
6 154 983 €
5 849 885 €
6 994 204 €
EBITDA
11 496 210 €
6 718 212 €
4 798 151 €
17 828 074 €
3 919 880 €
8 021 157 €
5 671 106 €
-579 480 €
10 142 013 €
Net margin
3.1%
2.5%
3.1%
2.4%
2.0%
2.4%
3.3%
2.6%
2.3%
Revenue and income statement
In 2024, LABORATOIRES ALCON achieves revenue of 236.0 M€. Activity remains stable over the period (CAGR: -3.1%). Vs 2023: +7%. After deducting consumption (162.3 M€), gross margin stands at 73.8 M€, i.e. a rate of 31%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 11.5 M€, representing 4.9% of revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 7.4 M€, i.e. 3.1% of revenue. This profit can be retained or distributed to shareholders.
Revenue (2024)
?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production
236 016 966 €
Gross margin (2024)
?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed
73 752 162 €
EBITDA (2024)
?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity
11 496 210 €
EBIT (2024)
?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals
11 859 919 €
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
7 367 506 €
EBITDA margin (2024)
?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability 5-10% : Average < 5% : Low
4.9%
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 39%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.0 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 5.0% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. Satisfactory level allowing partial financing of growth.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
0.032%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
39.378%
Cash flow / Revenue (2024)
?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates
5.047%
Repayment capacity (2024)
?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent 3-5 years : Fair > 5 years : Warning
0.001
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
0.0
0.0
0.883
0.0
0.191
0.713
17.072
16.848
0.032
Financial autonomy
48.722
57.217
28.917
32.135
35.08
29.116
31.672
35.441
39.378
Repayment capacity
0.0
0.0
0.027
0.0
0.008
0.008
0.588
0.586
0.001
Cash flow / Revenue
2.905%
3.129%
3.509%
4.507%
4.011%
9.728%
3.152%
3.605%
5.047%
Sector positioning
Debt ratio
0.032024
2022
2023
2024
Q1: 0.0
Med: 4.27
Q3: 43.96
Good-31 pts over 3 years
In 2024, the debt ratio of LABORATOIRES ALCON (0.03) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
39.38%2024
2022
2023
2024
Q1: 14.64%
Med: 38.36%
Q3: 60.56%
Good+7 pts over 3 years
In 2024, the financial autonomy of LABORATOIRES ALCON (39.4%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
0.0 years2024
2022
2023
2024
Q1: 0.0 years
Med: 0.0 years
Q3: 1.09 years
Good-9 pts over 3 years
In 2024, the repayment capacity of LABORATOIRES ALCON (0.00) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 187.34. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 1.9x. Coverage is limited: any activity downturn would jeopardize interest payments.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
187.344
Interest coverage (2024)
?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable 1.5-3 : Acceptable < 1.5 : Risk
1.867
Liquidity indicators evolution LABORATOIRES ALCON
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
213.862
279.857
150.282
163.655
177.909
166.941
183.426
197.319
187.344
Interest coverage
3.655
-28.737
2.511
4.035
5.823
1.715
3.999
2.717
1.867
Sector positioning
Liquidity ratio
187.342024
2022
2023
2024
Q1: 132.74
Med: 202.27
Q3: 325.9
Average
In 2024, the liquidity ratio of LABORATOIRES ALCON (187.34) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
1.87x2024
2022
2023
2024
Q1: 0.0x
Med: 0.41x
Q3: 6.25x
Good-17 pts over 3 years
In 2024, the interest coverage of LABORATOIRES ALCON (1.9x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 76 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 42 days. The gap of 34 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Inventory turnover is 21 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 90 days of revenue, i.e. 59.2 M€ to permanently finance. Notable WCR improvement over the period (-50%), freeing up cash.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
59 200 136 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
76 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
42 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
21 j
WCR in days of revenue (2024)
?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management
90 j
WCR and payment terms evolution LABORATOIRES ALCON
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
117 435 418 €
76 351 660 €
44 411 554 €
52 911 833 €
59 266 947 €
42 212 995 €
44 773 425 €
51 687 057 €
59 200 136 €
Inventory turnover (days)
40
32
39
19
24
22
25
24
21
Customer payment term (days)
64
53
63
72
69
69
73
79
76
Supplier payment term (days)
64
34
59
65
77
55
37
35
42
Positioning of LABORATOIRES ALCON in its sector
Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques
Valuation estimate
Based on 124 transactions of similar company sales
(all years),
the value of LABORATOIRES ALCON is estimated at
20 336 181 €
(range 10 550 766€ - 64 823 165€).
With an EBITDA of 11 496 210€, the sector multiple of 0.7x is applied.
The price/revenue ratio is 0.21x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
124 transactions
10550k€20336k€64823k€
20 336 181 €Range: 10 550 766€ - 64 823 165€
NAF 5 all-time
Valuation detail by method
Ajustez les pondérations selon votre analyse
EBITDA Multiple50%
11 496 210 €×0.7x
Estimation8 092 011 €
3 825 382€ - 29 451 969€
Revenue Multiple30%
236 016 966 €×0.21x
Estimation50 265 572 €
27 257 828€ - 152 255 244€
Net Income Multiple20%
7 367 506 €×0.8x
Estimation6 052 521 €
2 303 633€ - 22 103 041€
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)
Compare LABORATOIRES ALCON with other companies in the same sector:
Frequently asked questions about LABORATOIRES ALCON
What is the revenue of LABORATOIRES ALCON ?
The revenue of LABORATOIRES ALCON in 2024 is 236.0 M€.
Is LABORATOIRES ALCON profitable?
Yes, LABORATOIRES ALCON generated a net profit of 7.4 M€ in 2024.
Where is the headquarters of LABORATOIRES ALCON ?
The headquarters of LABORATOIRES ALCON is located in RUEIL MALMAISON (92500), in the department Hauts-de-Seine.
Where to find the tax return of LABORATOIRES ALCON ?
The tax return of LABORATOIRES ALCON is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does LABORATOIRES ALCON operate?
LABORATOIRES ALCON operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart